Autophagy: A Multifaceted Partner in Liver Fibrosis

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Mallat, Ariane ^a,b   Lodder, Jasper ^c,d,e   Teixeira Clerc, Fatima ^a,b   Moreau, Richard ^c,d,e,f   Codogno, Patrice ^d,g   Lotersztajn, Sophie ^c,d,e,f  

^a INSERM U955   (France)

^b FACULTÉ DE MÉDECINE   (France)

^c CENTRE DE RECHERCHE SUR L INFLAMMATION   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e Laboratoire d'Excellence INFLAMEX   (France)

^f BEAUJON HOSPITAL   (France)

^g INSTITUT NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOPHAGY; CELL ACTIVATION; EXTRACELLULAR MATRIX; FIBROGENESIS; HUMAN; IMMUNOCOMPETENT CELL; LIVER CELL; LIVER FIBROSIS; LIVER PROTECTION; MYOFIBROBLAST; REVIEW; STELLATE CELL; CELL TRANSDIFFERENTIATION; DRUG EFFECTS; GENETICS; INFLAMMATION; LIVER; LIVER CIRRHOSIS; METABOLISM; PATHOLOGY;

ANTIINFLAMMATORY AGENT;

ANTI-INFLAMMATORY AGENTS; AUTOPHAGY; CELL TRANSDIFFERENTIATION; EXTRACELLULAR MATRIX; HEPATIC STELLATE CELLS; HUMANS; INFLAMMATION; LIVER; LIVER CIRRHOSIS; MYOFIBROBLASTS;

EID: 84921482855     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/869390     Document Type: Review

References (47)

1. S. Lotersztajn, B. Julien, F. Teixeira-Clerc, P. Grenard, and A. Mallat, "Hepatic fibrosis: Molecular mechanisms and drug targets," Annual Review of Pharmacology and Toxicology, vol. 45, pp. 605-628, 2005.
2. A. Mallat and S. Lotersztajn, "Cellular mechanisms of tissue fibrosis. 5. Novel insights into liver fibrosis," American Journal of Physiology, vol. 305, no. 8, pp. C789-C799, 2013.
3. N. Mizushima, B. Levine, A. M. Cuervo, and D. J. Klionsky, "Autophagy fights disease through cellular self-digestion," Nature, vol. 451, no. 7182, pp. 1069-1075, 2008.
4. P. Boya and P. Codogno, "Micronucleophagy: A newmechanism to protect against chromosomal instability?" Cell Cycle, vol. 11, no. 4, pp. 645-646, 2012.
5. N. Mizushima, T. Yoshimori, and Y. Ohsumi, "The role of atg proteins in autophagosome formation," Annual Review of Cell and Developmental Biology, vol. 27, pp. 107-132, 2011.
6. J. L. Jewell and K. Guan, "Nutrient signaling to mTOR and cell growth," Trends in Biochemical Sciences, vol. 38, no. 5, pp. 233-242, 2013.
7. P. Codogno and A. J. Meijer, "Autophagy in the liver," Journal of Hepatology, vol. 59, no. 2, pp. 389-391, 2013.
8. P. Rautou, A.Mansouri, D. Lebrec, F. Durand, D. Valla, and R. Moreau, "Autophagy in liver diseases," Journal of Hepatology, vol. 53, no. 6, pp. 1123-1134, 2010.
9. M. J. Czaja, W. Ding, T. M. Donohue Jr. et al., "Functions of autophagy in normal and diseased liver," Autophagy, vol. 9, no. 8, pp. 1131-1158, 2013.
10. A. J.Meijer and P. Codogno, "Autophagy: Regulation and role in disease," Critical Reviews in Clinical Laboratory Sciences, vol. 46, no. 4, pp. 210-240, 2009.
11. R. Singh, S. Kaushik, Y. Wang et al., "Autophagy regulates lipid metabolism," Nature, vol. 458, no. 7242, pp. 1131-1135, 2009.
12. A. Efeyan, R. Zoncu, S. Chang et al., "Regulation of mTORC1 by the Rag GTPases is necessary for neonatal autophagy and survival," Nature, vol. 493, no. 7434, pp. 679-683, 2013.
13. T. Toshima, K. Shirabe, T. Fukuhara et al., "Suppression of autophagy during liver regeneration impairs energy charge and hepatocyte senescence in mice," Hepatology, vol. 60, no. 1, pp. 290-300, 2014.
14. V. Hernandez-Gea and S. L. Friedman, "Pathogenesis of liver fibrosis," Annual Review of Pathology, vol. 6, pp. 425-456, 2011.
15. D. Schuppan and Y. O. Kim, "Evolving therapies for liver fibrosis," The Journal of Clinical Investigation, vol. 123, no. 5, pp. 1887-1901, 2013.
16. J. P. Iredale, A. Thompson, and N. C. Henderson, "Extracellular matrix degradation in liver fibrosis: Biochemistry and regulation," Biochimica et Biophysica Acta: Molecular Basis of Disease, vol. 1832, no. 7, pp. 876-883, 2013.
17. J. X. Jiang, S. Venugopal, N. Serizawa et al., "Reduced nicotinamide adenine dinucleotide phosphate oxidase 2 plays a key role in stellate cell activation and liver fibrogenesis in Vivo," Gastroenterology, vol. 139, no. 4, pp. 1375-1384, 2010.
18. J. S. Duffield, S. J. Forbes, C.M. Constandinou et al., "Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair," The Journal of Clinical Investigation, vol. 115, no. 1, pp. 56-65, 2005.
19. F. Tacke and H. W. Zimmermann, "Macrophage heterogeneity in liver injury and fibrosis," Journal of Hepatology, vol. 60, no. 5, pp. 1090-1096, 2014.
20. J. Pradere, J. Kluwe, S. de Minicis et al., "Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice," Hepatology, vol. 58, no. 4, pp. 1461-1473, 2013.
21. P.Ramachandran, A. Pellicoro,M. A. Vernon et al., "Differential Ly-6C expression identifies the recruited macrophage phenotype, which orchestrates the regression ofmurine liver fibrosis," Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 46, pp. E3186-E3195, 2012.
22. M. K. Connolly, A. S. Bedrosian, J. Mallen-St. Clair et al., "In liver fibrosis, dendritic cells govern hepatic inflammation in mice via TNF-α," The Journal of Clinical Investigation, vol. 119, no. 11, pp. 3213-3225, 2009.
23. J. Jiao, D. Sastre, M. I. Fiel et al., "Dendritic cell regulation of carbon tetrachloride-induced murine liver fibrosis regression," Hepatology, vol. 55, no. 1, pp. 244-255, 2012.
24. J. R. Henning, C. S. Graffeo, A. Rehman et al., "Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice," Hepatology, vol. 58, no. 2, pp. 589-602, 2013.
25. S. Radaeva, R. Sun, B. Jaruga, V. T. Nguyen, Z. Tian, and B. Gao, "Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners," Gastroenterology, vol. 130, no. 2, pp. 435-452, 2006.
26. V. Krizhanovsky, M. Yon, R. A. Dickins et al., "Senescence of activated stellate cells limits liver fibrosis," Cell, vol. 134, no. 4, pp. 657-667, 2008.
27. T. A. Wynn and T. R. Ramalingam, "Mechanisms of fibrosis: Therapeutic translation for fibrotic disease," Nature Medicine, vol. 18, no. 7, pp. 1028-1040, 2012.
28. F. Meng, K. Wang, T. Aoyama et al., "Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice," Gastroenterology, vol. 143, no. 3, pp. 765.e3-776.e3, 2012.
29. A. Guillot, N. Hamdaoui, A. Bizy et al., "Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver," Hepatology, vol. 59, no. 1, pp. 296-306, 2014.
30. Z. Tan, X. Qian, R. Jiang et al., "IL-17A plays a critical role in the pathogenesis of liver fibrosis through hepatic stellate cell activation," Journal of Immunology, vol. 191, no.4,pp. 1835-1844, 2013.
31. A. Lemmers, C. Moreno, T. Gustot et al., "The interleukin-17 pathway is involved in human alcoholic liver disease," Hepatology, vol. 49, no. 2, pp. 646-657, 2009.
32. V. Hernández-Gea, Z. Ghiassi-Nejad, R. Rozenfeld et al., "Autophagy releases lipid that promotes fibrogenesis by activated hepatic stellate cells in mice and in human tissues," Gastroenterology, vol. 142, no. 4, pp. 938-946, 2012.
33. L. F. R. Thoen, E. L. M. Guimarães, L. Dollé et al., "A role for autophagy during hepatic stellate cell activation," Journal of Hepatology, vol. 55, no. 6, pp. 1353-1360, 2011.
34. V. Hernández-Gea, M. Hilscher, R. Rozenfeld et al., "Endoplasmic reticulum stress induces fibrogenic activity in hepatic stellate cells through autophagy," Journal of Hepatology, vol. 59, no. 1, pp. 98-104, 2013.
35. M. Amir, E. Zhao, L. Fontana et al., "Inhibition of hepatocyte autophagy increases tumor necrosis factor-dependent liver injury by promoting caspase-8 activation," Cell Death and Differentiation, vol. 20, no. 7, pp. 878-887, 2013.
36. J. Lodder, M. N. Chobert, S. Lotersztajn, and F. Teixeira-Clerc, "Macrophage autophagy protects from liver fibrosis," Hepatology, vol. 58, abstract 283A, 2013.
37. V. Deretic, T. Saitoh, and S. Akira, "Autophagy in infection, inflammation and immunity," Nature Reviews Immunology, vol. 13, no. 10, pp. 722-737, 2013.
38. A. Jacquel, S. Obba, L. Boyer et al., "Autophagy is required for CSF-1-induced macrophagic differentiation and acquisition of phagocytic functions," Blood, vol. 119, no. 19, pp. 4527-4531, 2012.
39. R. Zhou, A. S. Yazdi, P. Menu, and J. Tschopp, "A role for mitochondria in NLRP3 inflammasome activation," Nature, vol. 469, no. 7329, pp. 221-225, 2011.
40. S. Y. Chuang, C. H. Yang, C. C. Chou, Y. P. Chiang, T. H. Chuang, and L. C. Hsu, "TLR-induced PAI-2 expression suppresses IL-1β processing via increasing autophagy and NLRP3 degradation," Proceedings of the National Academy of Sciences of the United States of America, vol. 110, no. 40, pp. 16079-16084, 2013.
41. X. Liao, J. C. Sluimer, Y. Wang et al., "Macrophage autophagy plays a protective role in advanced atherosclerosis," Cell Metabolism, vol. 15, no. 4, pp. 545-553, 2012.
42. E. F. Castillo, A. Dekonenko, J. Arko-Mensah et al., "Autophagy protects against active tuberculosis by suppressing bacterial burden and inflammation," Proceedings of theNationalAcademy of Sciences of the United States of America, vol. 109, no. 46, pp. E3168-E3176, 2012.
43. C. P. de Castro, S. A. Jones, C. N. Cheallaigh et al., "Autophagy regulates IL-23 secretion and innate T cell responses through effects on IL-1 secretion," Journal of Immunology, vol. 189, no. 8, pp. 4144-4153, 2012.
44. W.-X. Ding, M. Li, X. Chen et al., "Autophagy reduces acute ethanol-induced hepatotoxicity and steatosis in mice," Gastroenterology, vol. 139, no. 5, pp. 1740-1752, 2010.
45. H. M. Ni, A. Bockus, N. Boggess, H. Jaeschke, and W. Ding, "Activation of autophagy protects against acetaminopheninduced hepatotoxicity," Hepatology, vol. 55, no. 1, pp. 222-232, 2012.
46. J. H. Wang, I. Ahn, T. D. Fischer et al., "Autophagy suppresses age-dependent ischemia and reperfusion injury in livers of mice," Gastroenterology, vol. 141, no. 6, pp. 2188.e6-2199.e6, 2011.
47. T. Hidvegi, M. Ewing, P. Hale et al., "An autophagy-enhancing drug promotes degradation of mutant α1-antitrypsin Z and reduces hepatic fibrosis," Science, vol. 329, no. 5988, pp. 229-232, 2010.